PL88804B1 - - Google Patents
Download PDFInfo
- Publication number
- PL88804B1 PL88804B1 PL170686A PL17068674A PL88804B1 PL 88804 B1 PL88804 B1 PL 88804B1 PL 170686 A PL170686 A PL 170686A PL 17068674 A PL17068674 A PL 17068674A PL 88804 B1 PL88804 B1 PL 88804B1
- Authority
- PL
- Poland
- Prior art keywords
- formula
- nitrogen
- carbon atoms
- acid
- general formula
- Prior art date
Links
- 239000002253 acid Substances 0.000 claims description 5
- 150000001875 compounds Chemical class 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- 238000009835 boiling Methods 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 125000004432 carbon atoms Chemical group C* 0.000 claims 3
- 229910052757 nitrogen Inorganic materials 0.000 claims 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 3
- YTFVRYKNXDADBI-SNAWJCMRSA-N 3,4,5-Trimethoxycinnamic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC(OC)=C1OC YTFVRYKNXDADBI-SNAWJCMRSA-N 0.000 claims 1
- 125000003341 7 membered heterocyclic group Chemical group 0.000 claims 1
- 125000001931 aliphatic group Chemical group 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 150000004982 aromatic amines Chemical class 0.000 claims 1
- 239000011230 binding agent Substances 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 150000002391 heterocyclic compounds Chemical class 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 claims 1
- 150000002829 nitrogen Chemical group 0.000 claims 1
- 125000004433 nitrogen atoms Chemical group N* 0.000 claims 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 1
- 239000003960 organic solvent Substances 0.000 claims 1
- 125000004430 oxygen atoms Chemical group O* 0.000 claims 1
- 125000004434 sulfur atoms Chemical group 0.000 claims 1
- 239000000243 solution Substances 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N acetic acid ethyl ester Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M NaHCO3 Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- ZMANZCXQSJIPKH-UHFFFAOYSA-N triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 4
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- ZYDQSPYFLQSONW-UHFFFAOYSA-N 2,3-dimethoxy-3-(2-methoxyphenyl)prop-2-enoic acid Chemical compound COC(C(O)=O)=C(OC)C1=CC=CC=C1OC ZYDQSPYFLQSONW-UHFFFAOYSA-N 0.000 description 1
- QOXOZONBQWIKDA-UHFFFAOYSA-N 3-hydroxypropyl Chemical group [CH2]CCO QOXOZONBQWIKDA-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-UUNJERMWSA-N Lactose Natural products O([C@@H]1[C@H](O)[C@H](O)[C@H](O)O[C@@H]1CO)[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1 GUBGYTABKSRVRQ-UUNJERMWSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- YNQLUTRBYVCPMQ-UHFFFAOYSA-N ethylbenzene Chemical compound CCC1=CC=CC=C1 YNQLUTRBYVCPMQ-UHFFFAOYSA-N 0.000 description 1
- 229940058172 ethylbenzene Drugs 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- ILWRPSCZWQJDMK-UHFFFAOYSA-O hydron;triethylazanium;chloride Chemical compound Cl.CC[NH+](CC)CC ILWRPSCZWQJDMK-UHFFFAOYSA-O 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L na2so4 Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 description 1
- 239000001184 potassium carbonate Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 239000010802 sludge Substances 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- ILWRPSCZWQJDMK-UHFFFAOYSA-N triethylazanium;chloride Chemical compound Cl.CCN(CC)CC ILWRPSCZWQJDMK-UHFFFAOYSA-N 0.000 description 1
Description
przedmiotem wynalazku stosuje sie te substancje zmieszane ze znanymi srodkami po¬ mocniczymi do tabletkowania, takimi jak skrobia, laktoza, talk i podobne. Mozna stosowac wszystkie znane w farmacji srodki do tabletkowania i dra- zetkowania. Do sporzadzania roztworów iniekcyj- nych stosuje sie szczególnie omawiane zwiazki w postaci chlorowodorków ze wzgledu na ich dobra rozpuszczalnosc w wodzie. Mozna oczywiscie sto¬ sowac do iniekcji nierozpuszczalne w wodzie zwiazki z dodatkiem znanych srodków do sporza¬ dzania zawiesin, emulgatorów i/lub srodków ulat¬ wiajacych rozpuszczanie.Przyklad I. Wytwarzanie zwiazku o wzorze 4. Do roztworu 36,3 g (0,1 moia) 3- -hydroksypropylo)-4-metylo-7,8- dwumetoksykuma- ryny w 300 ml bezwodnego benzenu dodaje sie ,1 g (0,1 mola) trójetyloaminy. Nastepnie w ciagu okolo 30 minut przy mieszaniu wkrapla sie w temperaturze pokojowej roztwór 25,66 (0,1 mola) chlorku kwasu 3,4,5-trójmetpksycynamonowego w 100 ml bezwodnego benzenu i miesza sie w tej temperaturze w ciagu 2 godzin, a nastepnie mie¬ szanine ogrzewa sie i utrzymuje w stanie wrzenia w ciagu 5 godzin, po czym wydzielony chlorowo¬ dorek trójetyloamoniowy odsacza na goraco.Przesacz przemywa sie woda, 10% wodnym roz¬ tworem wodoroweglanu sodu, ponownie woda i su¬ szy siarczanem sodu. Rozpuszczalnik odparowuje sie pod zmniejszonym cisnieniem i pozostalosc przekrystalizowuje sie z metanolu. Otrzymuje sie 52,6 g (85% wydajnosci teoretycznej 3-[Y-morfolino- -|3-(3',4/,5/-trójmetoksycynamonylooksy)-propylo]- 4- -metylo-7,8-dwumetoksykumaryny w postaci bez¬ barwnych krysztalów o temperaturze topnienia 168—175°C.Temperatura topnienia chlorowodorku wynosi 183°C.Przyklad II. Wytwarzanie zwiazku o wzo¬ rze 5. Do roztworu 10,8 g (0,03 mola) 3-(Y-pipery- dyno-|3-hydroksypropylo)-4-metylo- 7,8-dwumeto- ksykumaryny i 3,3 g (0,033 mola) trójetyloaminy w 70 ml bezwodnego dioksanu wkrapla sie roz¬ twór 8,6 g (0,033 mola) chlorku kwasu trójmeto- ksycynamonowego w 30 ml bezwodnego dioksanu.Mieszanine reakcyjna miesza sie w ciagu 2 godzin w temperaturze pokojowej i 5 godzin w tempera¬ turze 60°C, wydzielony chlorowodorek trójetylo¬ amoniowy odsacza na goraco i odparowuje roz¬ puszczalnik do suchosci. Pozostalosc zadaje sie octanem etylu, przemywa faze octanowa wodnym roztworem wodoroweglanu sodu, suszy weglanem potasu i odparowuje rozpuszczalnik pod zmniej¬ szonym cisnieniem. Po przekrystalizowaniu pozo¬ stalosci z malej ilosci octanu etylu lub benzenu uzyskuje sie 14 g (80,4% wydajnosci teoretycznej) 3-[Y-piperydyno-fH3',4',5'- trójmetoksycynamoilo- oksy)-propylo]-4-metylo- 7,8-dwumetoksykumaryny o temperaturze topnienia 160—162°C.W podobny sposób jak w przykladach I i II wytwarza sie: 3-[Y-pirolidyno-P-(3/,4',5/- trójmetoksycynamoilo- oksy)-propylo] -4-metylo-7,8- dwumetoksykumaryne o temperaturze topnienia 150—152°C. 3-[Y-szesciometylenoiminó-p-(3',4',5'_ trójmetoksy- cynamoilooksy)-propylo]-4-5metylO-7,8-dwumetoksy^ kumaryne o temperaturze topnienia zasady 123— 125°C. ¦.,...« 3-[Y-dwuetyloamino-p-(3/,4/,5/* .* taójmetoksycyna- moilooksy)-propylo] -4-metylo-7,8- dwumetoksyku¬ maryne o temperaturze topnienia zasady 138— 140°C. 3-[Y-tiomorfolino-p-(3',4',5'- trójmetoksycynamo- ilooksy)-propylo]-4-metylo-7,8- dwumetoksykuma¬ ryne o temperaturze topnienia zasady 165—167°C. PLThe present invention uses these substances mixed with known tableting aids such as starch, lactose, talc and the like. All known pharmaceutical tabletting and drageing agents can be used. The hydrochloride compounds mentioned in particular are used in the preparation of injection solutions because of their good solubility in water. Of course, it is also possible to inject water-insoluble compounds with the addition of known suspending agents, emulsifiers and / or dissolving aids. Example I. Preparation of the compound of formula 4. For a solution of 36.3 g (0.1) Moia) 3-hydroxypropyl) -4-methyl-7,8-dimethoxycumarine in 300 ml of anhydrous benzene is added, 1 g (0.1 mol) of triethylamine. Then, during about 30 minutes, while stirring, a solution of 25.66 (0.1 mol) of 3,4,5-triethpxycinnamic acid chloride in 100 ml of anhydrous benzene was added dropwise at room temperature and the mixture was stirred at this temperature for 2 hours, and then The mixture is heated and boiled for 5 hours, then the liberated triethylammonium chloride is filtered hot. The sludge is washed with water, 10% aqueous sodium hydrogen carbonate solution, again with water and dried with sodium sulfate. The solvent is evaporated off under reduced pressure and the residue is recrystallized from methanol. 52.6 g (85% of theory) of 3- [Y-morpholine- | 3- (3 ', 4 /, 5) -trimethoxycinnamonyloxy) propyl] - 4-methyl-7,8-dimethoxycoumarin are obtained. colorless crystals with a melting point of 168-175 ° C. The melting point of the hydrochloride is 183 ° C. Example 2 Preparation of the compound of formula 5. For a solution of 10.8 g (0.03 mole) of 3- (Y-piper) - dyno- β-hydroxypropyl) -4-methyl-7,8-dimethoxycoumarin and 3.3 g (0.033 mol) of triethylamine in 70 ml of dry dioxane, a solution of 8.6 g (0.033 mol) of acid chloride is added dropwise Trimethoxycinnamic acid in 30 ml of anhydrous dioxane. The reaction mixture is stirred for 2 hours at room temperature and for 5 hours at 60 ° C, the triethylammonium hydrochloride which has formed is filtered off while hot and the solvent is evaporated to dryness. with ethyl acetate, the acetate phase is washed with an aqueous sodium hydrogen carbonate solution, dried with potassium carbonate and the solvent is evaporated off under reduced pressure. If the residue is lysed from a small amount of ethyl acetate or benzene, 14 g (80.4% of theory) of 3- [γ-piperidine-fH3 ', 4', 5'-trimethoxycinnamoyl oxy) propyl] -4-methyl are obtained - 7,8-dimethoxycoumarins with a melting point of 160-162 ° C in a similar manner as in Examples I and II: 3- [Y-pyrrolidine-P- (3 /, 4 ', 5) -trimethoxycinnamoyl-oxy) -propyl ] -4-methyl-7,8-dimethoxycoumarin, m.p. 150-152 ° C. 3- [N-6-methyleneimine-p- (3 ', 4', 5'-trimethoxy-cinnamoyloxy) -propyl] -4-5-methyl-O-7,8-dimethoxy-coumarin, mp 123-125 ° C. ¦., ... «3- [Y-diethylamino-p- (3 /, 4 /, 5 / *. * Taymethoxycin-moyloxy) -propyl] -4-methyl-7,8-dimethoxycin, melting point bases 138-140 ° C. 3- [Y-thiomorpholine-p- (3 ', 4', 5'-trimethoxycinnamyloxy) propyl] -4-methyl-7,8-dimethoxycumarne, mp 165-167 ° C. PL
Claims (2)
Publications (1)
Publication Number | Publication Date |
---|---|
PL88804B1 true PL88804B1 (en) | 1976-09-30 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3635982A (en) | Amino-substituted-quinoxalinyloxazolidines and -oxazines | |
SU1331426A3 (en) | Method of production of carbostyryl derivatives | |
DK169409B1 (en) | Water-insoluble, pharmaceutically acceptable salts of substituted rapamycin derivatives and pharmaceutical compositions containing such a salt | |
DE69828276T2 (en) | New cyclic diamine compounds and remedies containing them | |
AU628583B2 (en) | Diphenylurea derivatives | |
EP0283390A2 (en) | Thiazole derivatives active on the cholinergic system, process for their preparation and pharmaceutical compositions containing them | |
US2913454A (en) | Certain cycloalkanotriazoles, process and intermediates | |
KR20010070442A (en) | Ether and amide compounds and preparation thereof as antidiabetics | |
US4088773A (en) | Acylamino derivatives | |
CN113121521A (en) | 6-trifluoromethyl-substituted benzothiazinone derivative and preparation method and application thereof | |
JPH01503233A (en) | pharmaceutical active compound | |
US20040038987A1 (en) | Novel cyclic diamine compounds and medicine containing the same | |
JP4001636B2 (en) | Activated iodine derivatives for the treatment of cancer and AIDS | |
US4032559A (en) | N,2-dicyanoacetimidates | |
PL109657B1 (en) | Method of producing new derivatives of pyrido/1,2a/pyrimidine | |
US2857384A (en) | New pyridazone compounds | |
US4853467A (en) | Nitrogen containing derivatives of epipodophyllotoxin glucosides | |
PL88804B1 (en) | ||
US4156005A (en) | Derivatives of 1,2-benzisoxazoles | |
SI9210142A (en) | 3-substituted 1,2,3,4-oxitriazole-5-imin compounds, procedure for their preparation and preparations comprising them | |
NO743980L (en) | ||
HU218274B (en) | N,n'-bis hydroxyalkyl and alkoxyalkyl-pyridine-2,4-dicarboxylic acid diamide derivatives and pharmaceutical compositions comprising such compounds and process for producing them | |
CN114507181B (en) | Propionic acid compound containing 5-substituted tetrahydroisoquinoline, pharmaceutical composition and application thereof | |
PL88953B1 (en) | ||
Yang et al. | Ion complexation properties of calix [6] arene derivatives: I. 1, 4-calix [6] crown-4 derivatives |